Core Viewpoint - The company is convening the first bondholders' meeting for the "Haiyou Convertible Bonds" in 2025 to discuss the termination of certain fundraising projects and the reallocation of remaining funds to new projects, which is seen as a strategic decision to enhance operational efficiency and align with market demands [7][8]. Meeting Procedures - The meeting will ensure the legal rights of all bondholders and maintain order, allowing only authorized participants to attend [1][2]. - Bondholders must sign in and present necessary documentation to participate in the meeting [2][3]. - The meeting will follow a structured agenda, including the announcement of attendees and their voting rights [5][7]. Agenda Items - The primary agenda item is the proposal to terminate the "Annual Production of 200 Million Square Meters of Photovoltaic Packaging Glue Film Project (Phase I)" and redirect the remaining funds to a new project for "Annual Production of 2 Million Square Meters of PDCLC Light Control Film Products (Phase I)" with an investment scale of 250 million yuan [7][8]. - The decision to terminate the previous project and initiate a new one is based on market conditions and the company's strategic development plan [8]. Voting and Rights - Bondholders will have the right to express their opinions and vote on the proposals, with each bond representing one vote [4][6]. - The meeting will utilize both on-site and remote voting methods, ensuring transparency and accountability in the decision-making process [4][5].

Core Viewpoint - The company has announced the termination of using raised funds for certain projects and the adjustment of investment amounts for some fundraising projects to enhance the efficiency of fund usage and accelerate strategic business layout [2] Summary by Relevant Sections Fund Usage Adjustment - The company plans to change the use of raised funds, specifically terminating the "Electronic Chemical Research Center Construction Project" and reallocating the funds to the "40,000 tons/year Ultra-Pure Electronic Chemicals Project (Shanghai)" [2] - The total investment for the "40,000 tons/year Ultra-Pure Electronic Chemicals Project (Shanghai)" has been adjusted from 570.99 million to 793.38 million [2] Project Investment Details - The revised investment allocation for the projects is as follows: - 30,000 tons/year Electronic Grade Phosphoric Acid Project (New Construction): Total Investment 419.47 million, Raised Funds 106.36 million - 40,000 tons/year Ultra-Pure Electronic Chemicals Project (Shanghai): Total Investment 793.38 million, Raised Funds 738.31 million - 20,000 tons/year Electronic Grade Ammonia and 10,000 tons/year Electronic Grade Ammonia Gas Project: Total Investment 255.73 million, Raised Funds 226.38 million - Total Investment across all projects: 1,468.58 million, Total Raised Funds: 1,071.04 million [2] Strategic Implications - The adjustments are aimed at maximizing the effectiveness of raised fund usage, improving the quality of project implementation, and aligning with the company's long-term development strategy [2]

Group 1 - The company has decided to terminate certain fundraising projects after re-evaluation, which will not significantly impact its normal operations and aligns with its long-term development strategy [1][2][3] - The board of directors approved the termination of the "Research and Development Center Construction Project" during the 18th meeting of the 6th board on July 14, 2025, and the unused raised funds will remain in a dedicated account [1][4] - The supervisory board and independent directors have also reviewed and approved the decision, confirming that it complies with relevant regulations and does not harm the interests of the company or its shareholders [2][3][4] Group 2 - The company is undergoing a change in its corporate structure, including a change in company type and registered capital, as well as the cancellation of the supervisory board [23][24][29] - The registered capital will decrease from 252,241,516 yuan to 251,737,562 yuan due to stock option exercises and the cancellation of repurchased shares [24][28] - The company will no longer have a supervisory board, with its functions being transferred to the audit committee of the board of directors [29][30] Group 3 - The company plans to increase capital for its subsidiary, Changsha Botai Electronics Co., Ltd., and subsequently for its subsidiary, Luoding Yada Co., Ltd., to optimize their capital structure and support business development [46][47] - The capital increase for Botai Electronics will amount to 200 million yuan, raising its registered capital from 15,569,450 yuan to 215,569,450 yuan [47] - The capital increase for Luoding Yada will also be 200 million yuan, increasing its registered capital from 123,344,370.86 yuan to 323,344,370.86 yuan [47][48]

Summary of Key Points Core Viewpoint The company has decided to change the use of part of the raised funds, adjust the internal investment structure of the fundraising projects, and postpone the timeline for the "IP Product and Operation Center Project" due to changes in market conditions and operational needs [1][14][15]. Fundraising Overview - The company raised a total of RMB 329.56 million through the issuance of 66,076,254 shares to 18 specific investors, with the net amount deposited into a designated account on March 16, 2021 [1][2]. - As of June 30, 2025, the total amount invested in fundraising projects was RMB 222.76 million, with a remaining balance of RMB 69.31 million [2][4]. Changes in Fundraising Use - The "Big Data Marketing Management Platform Construction Project" will be terminated, and the remaining funds will be redirected to the "IP Product and Operation Center Project" [6][9]. - The terminated project accounted for 7.64% of the net amount raised [6][9]. Reasons for Changes - The decision to terminate the "Big Data Marketing Management Platform Construction Project" was influenced by increased difficulty in obtaining and analyzing customer and product data, as well as a reassessment of resource allocation priorities [8][9]. - The company aims to enhance investment in core business areas such as research and development and market expansion, thereby reducing the urgency of the terminated project [8][10]. Internal Investment Structure Adjustment - The internal investment structure of the "IP Product and Operation Center Project" will be adjusted, with an increase in the budget for construction and a corresponding decrease in the budget for IP introduction and cultivation [12][13]. - The total commitment for the "IP Product and Operation Center Project" remains unchanged at RMB 274.39 million [12]. Project Timeline Postponement - The expected completion date for the "IP Product and Operation Center Project" has been postponed from December 31, 2025, to October 31, 2026, due to various construction challenges [12][13]. - Factors contributing to the delay include complex geological conditions, unique architectural features, and challenges in the curtain wall construction [12][13]. Impact of Changes - The adjustments are intended to optimize resource allocation and improve the efficiency of fund usage, ensuring that the project aligns with the company's long-term strategic goals [14][15]. - The company will adhere to relevant regulations and strengthen oversight of fund usage to ensure compliance and protect shareholder interests [14][15].

Fundraising Overview - The company raised a total of RMB 1,047,987,200.00 from the issuance of 16.64 million shares at a price of RMB 62.98 per share, with a net amount of RMB 920,537,016.65 after deducting issuance costs [1][2] - All raised funds have been deposited into a special account approved by the board of directors, and a tripartite supervision agreement has been signed with the sponsor and the supervising bank [2] Project Status - As of May 31, 2025, the company has invested RMB 19,993.20 million in the "Smart Health Medical ASSP Chip Upgrade and Industrialization Project," which represents 26.66% of the planned investment of RMB 75,000.00 million [2] - The company has been using its own funds and acceptance bills to pay for project-related expenses, with plans to replace these with raised funds in subsequent quarters [2] Project Delays - The company plans to adjust the expected completion dates for its fundraising projects due to the semiconductor market's cyclical adjustments and structural demand declines, as well as the rapid technological iterations in the industry [4][22] - The company has decided to delay the purchase of office space due to the overall downturn in the real estate market since 2022, opting to conduct project research and development in existing facilities [5] Project Necessity and Feasibility - The "Smart Health Medical ASSP Chip Upgrade and Industrialization Project" is deemed necessary due to the increasing importance of national health and the government's strategic push for health initiatives [6] - The project aligns with national policies promoting the health industry and is supported by local government initiatives, creating favorable conditions for implementation [6][12] Termination of Project - The "High-Precision PGA/ADC Signal Chain Chip Upgrade and Industrialization Project" is proposed to be terminated due to the unfavorable market conditions and the high competition in the semiconductor industry [13][14] - The remaining funds of RMB 15,284.06 million from the terminated project will be kept in the special account and used for new projects with strong profitability and growth potential [16] Adjustments to Project Implementation - The company plans to increase the scope of the "R&D Center Construction Project" to include the development of smart home control chips, reflecting a strategic shift towards the smart home market [19][20] - The implementation will now involve a wholly-owned subsidiary, Shenzhen Jinghua Zhixin Microelectronics Co., Ltd., to optimize resource allocation and ensure project success [17][19] Regulatory Compliance - The adjustments to the fundraising projects have been approved by the board and supervisory committee and will be submitted for shareholder approval, ensuring compliance with relevant regulations [21][24] - The company emphasizes that these changes will not adversely affect its normal operations or shareholder interests, aligning with its long-term strategic goals [22][23]

Meeting Overview - The first bondholders' meeting for "Heshun Convertible Bonds" will be held on July 14, 2025, at 15:00 in Hangzhou, Zhejiang Province [5][11] - The meeting aims to protect the legal rights of bondholders and ensure orderly proceedings [2][4] Bond Issuance and Fund Utilization - The company issued 3.38 million convertible bonds with a total amount of 338 million yuan, net proceeds amounting to 331.67 million yuan after expenses [7][10] - The original project "Annual Production of 124,000 Tons of Nylon New Materials" is being adjusted to "Annual Production of 50,800 Tons of Nylon New Materials" [11][15] Project Adjustment Details - The adjustment involves reallocating the previously raised funds, with 76.24 million yuan already utilized primarily for construction [11][12] - The new project will focus on producing various nylon products, including nylon 6 and nylon 66, with a total investment of 281.19 million yuan [15][18] Market and Industry Context - The nylon industry is experiencing rapid growth, with increasing demand for high-performance nylon products [19][20] - The company aims to enhance its product structure and market competitiveness by diversifying into higher-value nylon products [20][21] Future Prospects - The adjusted project is expected to achieve an internal rate of return of 21.36% after reaching full production [18] - The company is positioned to meet the growing market demand for nylon materials, particularly in high-end applications [19][20]

Core Viewpoint - Aojing Medical (688613) is undergoing adjustments to its fundraising projects, including changes in implementation subjects and locations, which are deemed necessary for the company's development and efficiency in using raised funds [1][2][3]. Company Announcements - Aojing Medical's second supervisory board meeting approved two resolutions: one regarding the postponement of certain fundraising projects, and the other concerning adjustments to the implementation subjects and locations of these projects [1][4]. - The company will hold its first extraordinary shareholders' meeting on July 11, 2025, to review the adjustments to the fundraising projects [1][4]. Fundraising Project Adjustments - As of December 31, 2024, Aojing Medical's fundraising projects include the Aojing Health Technology Industrial Park construction and other projects, with a total planned investment of 500.82 million yuan [2][3]. - The Aojing Health Technology Industrial Park construction project has been postponed from June 30, 2025, to June 30, 2027, due to strategic adjustments and the impact of national procurement policies [3]. - The company has canceled the implementation of the project by its subsidiary in Jiaxing and will return the remaining raised funds to its dedicated account [2].

Core Viewpoint - The company, 聚合顺新材料股份有限公司, is adjusting its fundraising project from an annual production capacity of 124,000 tons of nylon new materials to 50,800 tons, reflecting a strategic shift in production focus and capacity optimization [1][5][9]. Summary by Sections Project Adjustment Overview - The original project aimed for an annual production of 124,000 tons, including 104,000 tons of nylon 6 chips and 20,000 tons of copolymer nylon chips. The revised project will have a capacity of 50,800 tons, comprising 18,000 tons of nylon 6 copolymer chips, 14,000 tons of nylon 66 chips, 7,000 tons of nylon 66 copolymer chips, and 11,800 tons of modified nylon [1][8][12]. Funding and Financial Details - The company issued 3.38 million convertible bonds with a total amount of 338 million yuan, netting 331.67 million yuan after expenses. The bonds are set to be traded on the Shanghai Stock Exchange starting August 15, 2024 [2][3][12]. - The total investment for the new project is estimated at 281.19 million yuan, with 155.04 million yuan planned to be funded through the raised capital [8][12]. Reasons for Adjustment - The adjustment is driven by a reduced urgency for increasing nylon 6 chip production due to the anticipated release of production capacity from other projects. The company aims to focus on higher value-added products like copolymer nylon and nylon 66, which are expected to have broader market applications and enhance overall competitiveness [9][10][15]. - The company has already invested 76.24 million yuan in the original project, primarily in civil engineering, with a remaining balance of 78.80 million yuan [4][5][12]. Project Feasibility and Market Outlook - The project aligns with national policies supporting the nylon new materials industry, which is experiencing rapid growth. The company has established advanced production systems and a strong R&D team to support the new project [14][15]. - The expected internal rate of return for the project is 21.36%, with a payback period of 8.61 years [12][14]. Governance and Approval Process - The adjustments have been approved by the company's board and supervisory committee and will be submitted for shareholder and bondholder meetings for final approval [22][23][61].

Group 1 - The company held its 9th meeting of the 2nd Supervisory Board on June 26, 2025, with all three supervisors present, and the meeting was conducted in accordance with relevant laws and regulations [1][2] - The Supervisory Board approved a proposal to increase the investment amount for certain fundraising projects and to permanently supplement working capital with surplus raised funds, which aligns with the company's future operational development plans [1][2] - The voting results for the proposal were unanimous, with 3 votes in favor, 0 against, and 0 abstentions [2] Group 2 - The decision to adjust the investment total for the "Fluid Equipment Component Manufacturing Project" and conclude it was deemed beneficial for improving the efficiency of fund utilization and in the interest of the company and all shareholders [1] - The meeting's resolutions were documented and are available for review, ensuring transparency and compliance with regulatory requirements [2]

Core Viewpoint - The company has made a prudent decision to adjust the timeline for certain fundraising projects to reach their intended usable state, ensuring that this will not negatively impact the implementation of these projects or the interests of shareholders, particularly minority shareholders [1][2]. Group 1 - The second meeting of the supervisory board was convened on June 26, 2025, with all three supervisors present, and the meeting followed the required legal and procedural guidelines [1]. - The supervisory board unanimously approved the proposal to adjust the timeline for certain fundraising projects, with all votes in favor [1][2]. - The adjustment is based on the actual progress and feasibility of the projects, and it is confirmed that this decision will not adversely affect the company's operations or the interests of shareholders [2].